Ethica Industri Farmasi is primarily engaged in medicinals and botanicals activity. Its headquarters is located in Dki Jakarta. The company was founded in 1946. Ethica Industri Farmasi was established by Dr. Boenjamin Setiawan, a prominent figure in the Indonesian pharmaceutical industry. The company has grown to become a leading player in the production and distribution of pharmaceutical products in Indonesia. The primary business line of Ethica Industri Farmasi is the manufacturing of generic and branded pharmaceuticals, with a focus on prescription medications. The company also engages in the production of over-the-counter (OTC) drugs as a secondary business line. Ethica Industri Farmasi operates several branches across Indonesia, ensuring a strong local geographical footprint. The company's main product types include antibiotics, cardiovascular drugs, and pain management medications, marketed under well-known brand names such as Ethicol, Cardiopril, and Painex. Globally, Ethica Industri Farmasi has expanded its operations to several countries in Southeast Asia, enhancing its international presence. The company has established partnerships with various international pharmaceutical firms to bolster its research and development capabilities. Ethica Industri Farmasi is a member of the Indonesian Pharmaceutical Association and actively participates in industry events and forums. The company exports its products to several markets in Asia and Africa, contributing to its growing global footprint. With a commitment to improving healthcare outcomes, Ethica Industri Farmasi aims to provide high-quality, affordable medications to meet the needs of patients. The company's vision is to be a trusted partner in healthcare, driven by innovation and excellence in pharmaceutical manufacturing.
Headquarters
RT 010 RW 001
South Jakarta; Jakarta;
Postal Code: 12940
Contact Details: Purchase the PT Ethica Industri Farmasi report to view the information.
Website: http://www.ethica.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service